SofWave Medical Ltd. Overview
Pro stress-test →SofWave Medical is a developer and distributor of non-invasive aesthetic medical devices, offering ultrasound technology under the SUPERB brand for skin rejuvenation and wrinkle reduction, plus muscle toning technology under the Pure Impact brand. The company serves plastic surgeons, dermatologists, and aesthetic practitioners globally.
Strategic Profile
Pro stress-test →SofWave demonstrated exceptional growth momentum with 2025 revenue of $87.3-87.6 million, up approximately 46% year-over-year from $59.7 million in 2024. The company is evaluating a potential U.S. public offering and approved submission of a confidential Form F-1 Registration Statement to the SEC in January 2026.
Competitive Landscape
Pro stress-test →SofWave's primary competitor is U.S.-based Ulthera. Additional competitors in the aesthetic device space include Lumenis (laser/light-based), Cutera (platform), and Cynosure (energy-based systems). SofWave's proprietary SUPERB ultrasound technology and Pure Impact EMS module create differentiation, though competitive intensity is rising with new entrants in non-invasive aesthetics.
Industry Context
SofWave Medical Ltd. operates in Aesthetic Medical Devices / Non-Invasive Dermatology.
Key facts
Founded: 2015 · Headquarters: Yokneam Illit, Israel · Employees: 126 · Revenue: $87.3-87.6M (2025E) · Market cap: ~$460M